Literature DB >> 1904411

Evaluation of radiosurgery techniques with cumulative dose volume histograms in linac-based stereotactic external beam irradiation.

M C Schell1, V Smith, D A Larson, A Wu, J C Flickinger.   

Abstract

Radiosurgery at UCSF is performed with a 6-MV linear accelerator with tertiary collimation for improved small field definition. The dose delivery to the target relative to normal tissue is influenced by the number of arcs, the arc geometry, field size, and beam energy. The impact of arc number, arc geometry, and field size on the dose distribution from 6-MV X rays in a 16 cm spherical phantom has been evaluated through the use of cumulative dose volume histograms. Dose volume histograms were calculated for a) 1-5 and 10 arcs, and b) collimator sizes of 1.25, 2.0, and 3.0 cm. Differences between techniques were found at the 5-10% level for field sizes from 1.25 to 2.0 cm. It was shown that the finite dimension of the sphere and, by extension, head diminishes the differences between techniques for the larger field sizes. The effect of treating with two isocenters is also analyzed and an approach for improving the dose distribution is presented.

Entities:  

Mesh:

Year:  1991        PMID: 1904411     DOI: 10.1016/0360-3016(91)90245-y

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  2 in total

1.  3-D dosimetric methodology in multiple isocentres radiosurgery: the influence of dose-volume histograms on the choice of the reference isodose.

Authors:  D Lefkopoulos; M Schlienger; E Touboul; M C Plazas; L Merienne
Journal:  Med Biol Eng Comput       Date:  1994-07       Impact factor: 2.602

2.  Plan Quality and Treatment Efficiency for Radiosurgery to Multiple Brain Metastases: Non-Coplanar RapidArc vs. Gamma Knife.

Authors:  Haisong Liu; David W Andrews; James J Evans; Maria Werner-Wasik; Yan Yu; Adam Paul Dicker; Wenyin Shi
Journal:  Front Oncol       Date:  2016-02-11       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.